project id: TCGA-MESO; case submitter id: TCGA-ZN-A9VP; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.2; rna integrity number: 9.4; age at index: 51; days to birth: -18697; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1961; age at diagnosis: 18697; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 228.0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 573; initial weight: 20.0; sample id: 6c2df08b-0741-4833-b8a6-66cbed736dfc; sample submitter id: TCGA-ZN-A9VP-01A; portion id: 42bf03a4-782a-4515-bdea-0bf17ae6b5ba; portion submitter id: TCGA-ZN-A9VP-01A-11; slide id: 0608ca21-b0f4-42ee-beed-c767c840abed; slide submitter id: TCGA-ZN-A9VP-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;